期刊文献+

脑钠肽对急性冠状动脉综合征近期预后的评价 被引量:3

The short-term prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
原文传递
导出
摘要 目的:探讨脑钠肽(BNP)对急性冠状动脉综合征(ACS)近期预后评价的价值.方法:使用Triage BNP干氏床旁快速检测方法对106例ACS患者入院1~3 d的BNP水平进行测量,随访1个月,分为存活组和死亡组.结果:①存活组和死亡组BNP水平差异有统计学意义(P<0.01); ②单因素分析表明:血BNP≥172 ng/L(中位数)和Killip分级Ⅱ级以上为1个月内心源性死亡的预测因素(均P<0.01 );③Logistic回归分析表明:吸烟和血BNP≥596 ng/L(75%百分位数)为1个月内心源性死亡的独立预测因素(OR=5.50,P<0.05;OR=21.19,P<0.01).结论:ACS患者血BNP水平与其近期预后相关. Objective: To investigate the short-term prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes(ACS). Method:A total of 106 patients with acute coronary syndrome,whose blood BNP concentrations were measured with Triage BNP test,within 13 days after onset of ischemia symptoms,were divided into 2 groups:the survival and the non-survival, according to the results of 1 mouth follow - up. Result:The blood BNP concentration in the non-survival was significantly higher than in the survival;univariate analysis showed that ,BNP (172 ng/L,median)and Killip class (Ⅱ Ⅳ) were prognostic factors of short-term cardiac death in patients with ACS(P< 0.01);Logistic regression analysis indicated that smoking and BNP(596 ng/L,75% percentile) were independent predictors of short-term cardiac death in patients with ACS (OR= 5.5, P< 0.05;OR= 21.19, P< 0.01).Conclusion:Blood BNP level was related to short-term prognosis in patients with ACS.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2005年第3期176-178,共3页 Journal of Clinical Cardiology
关键词 急性冠状动脉综合征 脑钠肽 预后 Acute coronary syndrome B-type/Brain natriuretic peptide Prognosis
  • 相关文献

参考文献10

  • 1葛均波,梁春.急性冠脉综合征(ACS)的诊治进展 冠脉造影法评价急性冠脉综合征发病机制及预后[J].医师进修杂志,2002,25(2):1-3. 被引量:21
  • 2de Lemos J A,Marrow D A,Bentley J H,et al.The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.N Engl J Med ,2001,345:1014-1021.
  • 3Morrow D A,de Lemos J A,Sabatine M S, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angia/ non -ST -elevation myocardial infarction B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.J Am Coll Cardiol, 2003, 41:1264-1272.
  • 4Omland T J, Persson A, Leong N, et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndrome .Circulation, 2002,106:2913-2925.
  • 5Galvani M , Ferrini D, Ottani F. Natriuretic peptide for risk stratification of patients acute coronary syndromes.Eur J Heart Fail, 2004,6:327-333.
  • 6Ishii J,Nomura M,Nakamura Y ,et al.Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure.Am J Cardiol,2002,89:691-695.
  • 7White H D, French J K. Use of natriuretic peptide levels for risk assessment in non-ST-elevation acute coronary syndrome.JACC, 2003,42:1917-1920.
  • 8Hama N, Itoh H, Shirakami G, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation, 1995,92:1558-1564.
  • 9Tateishi J,Masutani M,Ohyanagi M,et al.Transient increase in plasma brain(B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty.Clin Cardiol, 2000,23:776-780.
  • 10Brummett B H,Babyak M A,Siegler I C,et al.Effect of smoking and sedentary behavior on the association between depressive symptoms and mortality from coronary heart disease.Am J Cardiol, 2003,92:529-532.

共引文献20

同被引文献43

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部